Induced pluripotent stem cells with NOTCH1 gene mutation show impaired differentiation into smooth muscle and endothelial cells: Implications for bicuspid aortic valve-related aortopathy
DOI: 10.1016/j.jtcvs.2018.02.087
Authors: Jiao Jiao; Weihua Tian; Ping Qiu; Elizabeth L. Norton; Michael M. Wang; Y. Eugene Chen; Bo Yang
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “E8”. “PSC” should be “downregulated” for “NOTCH1”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| Y27632 | 1.0e-5 | mol/l |
Ideally, “PSC” should express “POU5F1” at the end of culture.
Step 2: mesoderm 1
day 1 ~ 2
culture “adherent” human PSC in “DMEM/F12” for “1” days. “PSC” should be “downregulated” for “NOTCH1”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| Glutamine | — | — |
| PSA | — | — |
| B27 | — | — |
| MTG | 4.0e-4 | mol/l |
| Ascorbic Acid | 0.05 | g/l |
| BMP4 | 2.5e-5 | g/l |
| CHIR90021 | 6.0e-6 | mol/l |
Ideally, “CVPC” should express “ISL1”, “NKX2.5”, “myocardin” at the end of culture.
Step 3: endothelial 1
day 2 ~ 4
culture “adherent” human CVPC in “Stempro34” for “2” days. “CVPC” should be “downregulated” for “NOTCH1”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| Stempro34 supplement | — | — |
| PSA | — | — |
| Glutamine | — | — |
| VEGF | 5.0e-5 | g/l |
Ideally, “EC” should express “PECAM1”, “CD105” at the end of culture.